Large Intestinal Cancer
Copyright ©The Author(s) 2002.
World J Gastroenterol. Jun 15, 2002; 8(3): 496-498
Published online Jun 15, 2002. doi: 10.3748/wjg.v8.i3.496
Table 1 Relationship between expression of TGF-β1 and clinicopathologic findings
Clinic-pathologic parametersTGF-β1 expression(%)
Positive(n = 37)Negative(n = 61)
Male20 (37.8)33 (62.3)
Female17 (37.8)28 (62.2)
Age (y)55 ± 1357 ± 12
Histology: differentiation
Well9 (52.9)8 (47.1)
Moderate15 (31.9)32 (68.1)
Poor13 (38.2)21 (61.8)
Depth of invasion
T1-T217 (28.3)43 (71.7)
T3-T420 (52.6)18 (47.4) a
Lymph node metastasis
Present18 (51.4)17 (48.6)
Absent19 (30.2)44 (69.8) a
Dukes Stage
I8 (23.5)26 (76.5)
II9 (31.1)20 (68.9)
III + IV20 (57.1)15 (42.9) a
VEGF expression
Positive21 (58.3)15 (41.7)
Negative16 (25.8)46 (74.2) a
MVD (-x ± s)54 ± 1846 ± 15a